The Advocacy to Control Tuberculosis Internationally (ACTION) project is an international partnership of advocates working to mobilise resources to treat and prevent the spread of tuberculosis (TB), a global disease that kills almost 2 million people every year. ACTION's underlying premise is that more rapid progress can be made against the TB epidemic by building increased support for effective TB control among key policymakers and other opinion leaders in both high TB burden and donor countries.
Alongside ACTION partners in donor countries of Australia, Canada, France, Japan and the United States, RESULTS UK works to increase political will to mobilise greater financial support for addressing TB.
In two high TB burden countries, India and Kenya, ACTION partners work with national governments and civil society to advocate for increased resources and work to overcome key policy constraints that have impeded successful and rapid expansion of TB treatment.
Since 2004, RESULTS has been instrumental in working towards ACTION’s goals:
- RESULTS played a key role in establishing the first All-Party Parliamentary Group on Global Tuberculosis (APPG on Global TB). The APPG on Global TB is a cross-party parliamentarian effort to address the growing scale and impact of the TB epidemic and to reinforce the UK’s commitment to halting and reversing the rate of TB worldwide.
- In 2008, RESULTS was closely involved with the establishment of the UK Coalition to Stop TB (the national partner of the global Stop TB Partnership) and currently serves as the Coalition’s secretariat. In a short time, the Coalition has developed into a robust network with about 35 member organisations in the UK collaborating to increase the level of awareness, commitment and political will to address TB through coordinated actions and a unified voice.
- Given the urgent need to deliver new and improved TB tools, RESULTS has been a leader in advocating for increased funding for research and development (R&D) from the UK’s Department for International Development (DFID). In part due to our advocacy, on World TB Day 2010 DFID announced a £12 million grant for research into new tools to fight TB. The tools we currently use to fight the disease are hopelessly out of date – for example the only vaccine available for use was invented 90 years ago and is not very effective. The grant includes £8 million for Aeras to help develop a new TB vaccine and £4 million for the Global Alliance for TB Drug Development.